The role of the adenosinergic system in lung fibrosis

被引:40
作者
Della Latta, Veronica [1 ,2 ]
Cabiati, Manuela [1 ]
Rocchiccioli, Silvia [1 ]
Del Ry, Silvia [1 ]
Morales, Maria-Aurora [1 ]
机构
[1] CNR, Inst Clin Physiol, I-56126 Pisa, Italy
[2] Univ Siena, I-53100 Siena, Italy
关键词
Adenosine; Adenosine receptors; Lung disease; Idiopathic pulmonary fibrosis; Bleomycin; IDIOPATHIC PULMONARY-FIBROSIS; RECEPTOR; MECHANISMS; INFLAMMATION; PATHOGENESIS; EXPRESSION; PROGRESS; DISEASE; TARGETS; MODELS;
D O I
10.1016/j.phrs.2013.08.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine (ADO) is a retaliatory metabolite that is expressed in conditions of injury or stress. During these conditions ATP is released at the extracellular level and is metabolized to adenosine. For this reason, adenosine is defined as a "danger signal" for cells and organs, in addition to its important role as homeostatic regulator. Its physiological functions are mediated through interaction with four specific transmembrane receptors called ADORA1, ADORA2A, ADORA2B and ADORA3. In the lungs of mice and humans all four adenosine receptors are expressed with different roles, having pro- and anti-inflammatory roles, determining bronchoconstriction and regulating lung inflammation and airway remodeling. Adenosine receptors can also promote differentiation of lung fibroblasts into myofibroblasts, typical of the fibrotic event. This last function suggests a potential involvement of adenosine in the fibrotic lung disease processes, which are characterized by different degrees of inflammation and fibrosis. Idiopathic pulmonary fibrosis (IPF) is the pathology with the highest degree of fibrosis and is of unknown etiology and burdened by lack of effective treatments in humans. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:182 / 189
页数:8
相关论文
共 67 条
[51]   Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder [J].
Selman, M ;
Pardo, A .
RESPIRATORY RESEARCH, 2001, 3 (01)
[52]   In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats [J].
Serrano-Mollar, A ;
Closa, D ;
Prats, N ;
Blesa, S ;
Martinez-Losa, M ;
Cortijo, J ;
Estrela, JM ;
Morcillo, EJ ;
Bulbena, O .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (06) :1037-1048
[53]   Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment [J].
Sime, PJ ;
O'Reilly, KMA .
CLINICAL IMMUNOLOGY, 2001, 99 (03) :308-319
[54]   Adenosine in the airways: Implications and applications [J].
Spicuzza, L ;
Di Maria, G ;
Polosa, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 533 (1-3) :77-88
[55]   Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury [J].
Sun, Chun-Xiao ;
Zhong, Hongyan ;
Mohsenin, Amir ;
Morschl, Eva ;
Chunn, Janci L. ;
Molina, Jose G. ;
Belardinelli, Luiz ;
Zeng, Dewan ;
Blackburn, Michael R. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (08) :2173-2182
[56]   A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury [J].
Sun, CX ;
Young, HW ;
Molina, JG ;
Volmer, JB ;
Schnermann, J ;
Blackburn, MR .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) :35-43
[57]  
Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK
[58]   Mechanisms of pulmonary fibrosis [J].
Thannickal, VJ ;
Toews, GB ;
White, ES ;
Lynch, JP ;
Martinez, FJ .
ANNUAL REVIEW OF MEDICINE, 2004, 55 :395-417
[59]   Molecular and cellular mechanisms of pulmonary fibrosis [J].
Todd, Nevins W. ;
Luzina, Irina G. ;
Atamas, Sergei P. .
FIBROGENESIS & TISSUE REPAIR, 2012, 5
[60]   Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists [J].
van Muijlwijk-Koezen, JE ;
Timmerman, H ;
Vollinga, RC ;
Künzel, JFV ;
de Groote, M ;
Visser, S ;
Ijzerman, AP .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) :749-762